Header image for  Pareto Securities’ 11th Annual Healthcare Conference
Profile image for Asarina Pharma

Asarina Pharma Exhibitor

Type of industry

Biotech

Presentation
The powerful neurosteroid Allopregnanolone (ALLO) is implicated in a wide range of stress- and compulsion-related conditions from menstrual migraine to Tourette, OCD, PTSD, PMDD, compulsive gambling, addiction—and more.​ Asarina´s novel treatment Sepranolone is the endogenous compound that inhibits and modulates ALLO. It is the first of a new family of GAMSA compounds (GABAA Modulating Steroid Antagonists). GAMSAs target the powerful neurosteroids that act on the brain’s GABAA receptors. GAMSAs represent a new paradigm shift in the treatment of still widely untreated stress- and compulsion-related conditions.

Presentations

Asarina Pharma

Wednesday September 2, 2020 15:00 - 15:30 CEST Room 2

Representatives

Peter Nordkild SpeakerExhibitor

CEO
Asarina Pharma